Peptide Therapy Cost: What to Actually Expect in 2026

The Real Cost Range

Most people pay between $150 and $1,300+ per month for peptide therapy. That's a wide range because "peptide therapy" covers everything from a $150/month BPC-157 protocol to brand-name Wegovy at retail pharmacy prices.

Here's the honest breakdown. Brand-name GLP-1 injectables still run $1,000 to $1,400 per month at list price, but new self-pay options from Novo Nordisk and Eli Lilly now start at $149 to $299 per month. Compounded semaglutide still exists in the $200 to $500 per month range, though availability has tightened. Peptides like BPC-157 or growth hormone secretagogues run $150 to $350 per month through compounding pharmacies — when you can get them.

Those numbers don't always include consultations, bloodwork, or follow-up visits. We'll get into those costs below.

Brand-Name vs Compounded: Why the Price Gap Is So Big

The single biggest factor in what you'll pay is whether you're getting a brand-name pharmaceutical or a compounded version.

Brand-name peptides like Wegovy and Mounjaro are manufactured by large pharma companies (Novo Nordisk and Eli Lilly, respectively), priced to recoup billions in R&D and clinical trial costs, and sold through retail pharmacies. The sticker prices reflect monopoly pricing, marketing budgets, and shareholder expectations. Not just the cost of making the drug.

Compounded peptides are made by licensed compounding pharmacies under FDA rules that allow pharmacists to prepare custom formulations when there's a clinical need. Compounding pharmacies don't carry the same overhead. They're buying bulk active pharmaceutical ingredients and preparing doses to order. That's why compounded semaglutide has historically cost $200 to $400 per month while brand-name Wegovy lists at ~$1,349/month.

The tradeoff: compounded peptides don't go through the same FDA approval process as brand-name drugs. Quality depends heavily on the pharmacy. A 503B outsourcing facility with FDA registration and third-party testing is a very different operation than a loosely regulated 503A pharmacy cutting corners. The regulatory landscape has also shifted — the FDA ended the semaglutide shortage in February 2025, and grace periods for existing compounded supplies expired in May 2025. Compounded semaglutide is still available through some pharmacies, but access is shrinking. Ask your provider where they source from, and don't accept vague answers.

Semaglutide Cost Breakdown

Semaglutide is the most-prescribed peptide for weight loss right now, and pricing varies dramatically depending on how you get it.

Wegovy injectable (brand-name, weight loss indication): ~$1,349/month list price. With commercial insurance that covers it, copays range from $0 to $300 per month. Through NovoCare savings programs, eligible patients can get the injectable for $299/month. Only about 20-25% of commercial plans cover weight loss drugs, so most people pay out of pocket.

Wegovy pill (launched January 2026): Novo Nordisk's oral semaglutide for weight loss starts at ~$149/month without insurance at the lowest dose. Maintenance dose runs $349/month through NovoCare savings. This is the biggest pricing shift in the GLP-1 market since compounded versions hit the scene.

Ozempic (brand-name, diabetes indication): $900 to $1,100 per month at retail. Insurance coverage is more common here because the diabetes indication has been around longer. Some providers prescribe Ozempic off-label for weight loss, which can make insurance coverage hit-or-miss.

Compounded semaglutide: $200 to $500 per month through remaining telehealth clinics and weight loss providers. The FDA ended the semaglutide shortage in February 2025 and grace periods for existing compounded inventory expired in May 2025. Some 503B pharmacies still compound it, but availability is shrinking fast. If you're currently on compounded semaglutide, plan a transition strategy with your provider.

Tirzepatide Cost Breakdown

Tirzepatide is the dual GIP/GLP-1 agonist that's shown even stronger weight loss results than semaglutide in head-to-head data. The SURMOUNT-1 trial showed average weight loss of 22.5% at the highest dose over 72 weeks. Pricing reflects that demand.

Mounjaro (diabetes indication): $1,000 to $1,100 per month at retail without insurance. Insurance coverage for diabetes patients has been improving.

Zepbound (weight loss indication): $1,050 to $1,200 per month at retail list price. Zepbound was the most prescribed weight management medication in 2025. Self-pay through LillyDirect starts at $299/month for the 2.5mg dose, with higher doses costing more. Big news for seniors: starting April 2026, Medicare covers Zepbound at a maximum of $50/month out-of-pocket. Federal law still prohibits Medicare from covering Wegovy or semaglutide for weight loss, so Zepbound is the only GLP-1 weight loss option for Medicare patients.

Compounded tirzepatide: Effectively unavailable. The FDA ended the tirzepatide shortage and compounding pharmacies have been unable to continue production. If a provider is still offering "compounded tirzepatide," ask hard questions about where it's coming from.

BPC-157 and Growth Hormone Peptide Costs

Outside the GLP-1 weight loss category, peptide therapy costs tend to run lower.

BPC-157 is popular for injury recovery, gut healing, and inflammation. When available through a licensed provider and compounding pharmacy, expect $150 to $300 per month. Some clinics sell it as part of a "recovery stack" combined with TB-500, which can push the price to $250 to $400 per month. BPC-157 isn't FDA-approved, so this is entirely cash-pay. Here's the catch: the FDA placed BPC-157 in Category 2 (banned from compounding). In February 2026, RFK Jr. announced that approximately 14 of the 19 restricted peptides — including BPC-157 — will be moved back to Category 1, which would allow compounding again. That formal reclassification is still pending, so check current status before assuming you can get it.

CJC-1295 / Ipamorelin has been the most common growth hormone secretagogue combination, priced at $200 to $450 per month when available. Both peptides were removed from FDA Category 2 in September 2024, but they were not added to Category 1. The result: compounding remains effectively suspended. No clear timeline for resolution. If a clinic is advertising these, verify their sourcing carefully.

Sermorelin runs $150 to $350 per month. It was actually FDA-approved at one point (as Geref) but has been discontinued as a brand-name product. Compounded versions are still available and sermorelin has become a more common alternative now that CJC-1295/Ipamorelin access is restricted.

PT-141 (Bremelanotide) for sexual dysfunction costs $100 to $250 per month. The brand-name version, Vyleesi, costs significantly more at roughly $900+ per dose through retail pharmacies.

These peptides don't have the blockbuster demand (or prices) of GLP-1s. But costs add up if you're running multiple peptides simultaneously, which some protocols call for.

What Else You'll Pay For

The price of the peptide itself is only part of the equation. Here's where the rest of your money goes.

Initial consultation: $0 to $300. Many telehealth providers roll the consultation into a monthly membership. Brick-and-mortar clinics with in-person evaluations tend to charge separately, usually $150 to $300 for an initial visit.

Bloodwork: $100 to $400 depending on the panel. A standard baseline for GLP-1 therapy includes a metabolic panel, thyroid function, A1C, and sometimes lipids. Some clinics include bloodwork in their pricing. Others send you to a lab and you pay separately. Growth hormone peptide protocols often add an IGF-1 test.

Follow-up visits: $50 to $150 each, or included in a monthly membership. Good providers will check in with you every 4 to 8 weeks, especially during dose titration.

Supplies: $10 to $30 per month for syringes, alcohol swabs, and sharps containers if your clinic doesn't supply them. Minor cost, but it's there.

Monthly program fees: Some telehealth platforms charge a membership fee of $50 to $150 per month on top of medication costs. This typically covers provider access, messaging, and refill management. Read the fine print — the total cost is what matters, not how they break it up.

Does Insurance Cover Peptide Therapy?

For brand-name semaglutide and tirzepatide with a diabetes diagnosis, coverage has gotten better. Most major insurers cover Ozempic and Mounjaro for type 2 diabetes patients, though prior authorization is usually required.

For weight loss? It's a different story. Only about 20-25% of commercial insurance plans cover weight loss drugs like Wegovy and Zepbound. Even when a plan covers the drug, restrictions like step therapy (try lifestyle changes first) or BMI thresholds are common.

Medicare is a mixed bag. Starting April 2026, Medicare covers Zepbound for weight loss at a maximum $50/month out-of-pocket cost. That's a major shift. But federal law still prohibits Medicare from covering semaglutide (Wegovy) for weight loss. If you're on Medicare and want GLP-1 treatment for weight management, Zepbound is your covered option.

Compounded peptides are almost never covered by insurance. Same goes for BPC-157, growth hormone peptides, and other non-FDA-approved therapies. These are cash-pay.

If you have insurance, it's worth having your provider submit a prior authorization for brand-name medications before assuming you'll pay out of pocket. Some people are surprised to find their plan actually covers it — they just never asked.

How to Keep Costs Down

There are real ways to lower what you spend without buying questionable products off the internet.

Compare total cost, not just medication cost. A clinic charging $350/month with consultations and bloodwork included can be cheaper than one charging $200/month for the peptide alone, then billing $250 for a required quarterly visit and $200 for labs.

Ask about dose optimization. For GLP-1s, some patients maintain results at lower doses after reaching their target weight. A lower maintenance dose costs less and reduces side effects.

Use manufacturer savings programs. LillyDirect offers Zepbound self-pay starting at $299/month. NovoCare offers Wegovy injectable at $299/month and the new Wegovy pill starting at $149/month. These programs have cut brand-name costs by 75%+ compared to list price. No insurance required.

Look at telehealth providers. Their overhead is lower than brick-and-mortar clinics, and that savings usually passes to you. Just confirm they're using licensed pharmacies and employ licensed prescribers.

Don't stack peptides you don't need. Some clinics will enthusiastically sell you a protocol with three or four peptides. There's a time and place for combination therapy, but more expensive doesn't mean more effective. Start with one peptide that targets your main goal and add only if there's a clear reason.

Avoid "research grade" peptides. Yes, they're cheaper. They're also unregulated, potentially contaminated, and come with zero medical oversight. The savings aren't worth the risk to your health.

Peptide Therapy Cost FAQs

How much does semaglutide cost per month?

Brand-name Wegovy injectable lists at ~$1,349/month, but NovoCare savings bring that to $299/month for self-pay patients. The new Wegovy pill starts at ~$149/month at the lowest dose, $349/month at maintenance through NovoCare. Compounded semaglutide runs $200 to $500 per month through remaining providers, though availability is shrinking after FDA shortage grace periods expired in May 2025. With insurance, brand-name copays vary widely from $0 to $300+ depending on your plan and diagnosis.

Is compounded semaglutide cheaper?

It has been, but the gap is closing and the availability picture has changed. Compounded semaglutide costs $200 to $500/month versus ~$1,349/month list price for Wegovy. But with the Wegovy pill starting at $149/month through NovoCare and LillyDirect offering Zepbound at $299/month, brand-name self-pay options are now competitive with compounded pricing. The FDA ended the semaglutide shortage in February 2025, and compounding grace periods expired in May 2025. Compounded semaglutide is still available through some pharmacies, but long-term access is uncertain.

Why is peptide therapy so expensive?

For brand-name GLP-1s, the pricing reflects pharmaceutical company R&D costs, patent exclusivity, and massive consumer demand. For compounded peptides, you're paying for the active ingredient, pharmacy compounding labor, provider oversight, and clinic margins. Peptide therapy also sits outside insurance coverage for most use cases, which means there's no negotiated rate pulling prices down. The cash-pay market sets its own prices.

Do you need bloodwork for peptide therapy?

Any responsible provider will require baseline bloodwork before prescribing. For GLP-1 agonists, that typically means a metabolic panel, A1C, and thyroid function tests. For growth hormone peptides, IGF-1 levels are standard. Bloodwork costs $100 to $400 depending on the panel and where it's drawn. Some clinics include it in their pricing, others don't. Skipping bloodwork isn't a way to save money — it's a red flag about the provider.

Are there hidden fees with peptide clinics?

Sometimes. The most common surprises are separate charges for the initial consultation, required quarterly bloodwork billed outside the monthly fee, shipping and handling for medications, cancellation or early termination fees on subscription plans, and mandatory "membership" fees on top of medication costs. Ask for a full cost breakdown before signing up. A clinic that's upfront about total pricing is one worth trusting. One that buries fees in fine print is telling you something about how they operate.